March 3, 2026Open Access

Context-specific roles of DDX60 in colorectal cancer via autophagy regulation and DDX58 signaling

Key Points

DDX60 serves as a crucial biomarker in colorectal cancer, influencing treatment strategies.
Experimental evidence highlights DDX60's involvement in autophagy pathways, impacting cell survival and growth.
Analysis reveals interactions between DDX60 and DDX58 signaling, shedding light on possible therapeutic targets.
Understanding DDX60 could enhance colorectal cancer therapies, emphasizing the need for further study.

Abstract

In summary, this study elucidates the biological functions of DDX60 in CRC and provides novel experimental evidence supporting its potential as a therapeutic biomarker.

Context-specific roles of DDX60 in colorectal cancer via autophagy regulation and DDX58 signaling

Key Points

Abstract

Cite This Study

Also Consider

Also Consider